There were 159 press releases posted in the last 24 hours and 437,637 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
AIM ImmunoTech 在评估 Ampligen® 治疗 COVID 后遗症的 2 期研究中招募首位受试者并完成给药

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image